miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5
Abstract Background miR-198 is involved in the formation, migration, invasion, and metastasis of various malignant cancers. However, the function and mechanism of action of miR-198 in the tumorigenesis of renal cell carcinoma (RCC) remain elusive. Here, we aimed to explore the role of miR198 in RCC....
Main Authors: | Chao Yuan, Zhenhong Su, Shengjie Liao, Duanzhuo Li, Zhiwen Zhou, Yawen Wang, Mingchun Quan, Lingling Zeng, Cai Lv, Chenyi Shen, Weida Gong, Jianfeng Wu, Xiaogang Chen, Wenbing Hu, Xu Lv, Wenxia Si, Xin Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-021-02092-7 |
Similar Items
-
Expression of anti-apoptothic protein survinin and its gene BIRC5 in primary breast carcinoma as a prognostic factor for the disease
by: E. A. Shlyakhtunov
Published: (2019-02-01) -
Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma
by: Giuseppe Troiano, et al.
Published: (2018-09-01) -
Genetic polymorphisms and epigenetic regulation of survivin encoding gene, BIRC5, in multiple sclerosis patients
by: Dariush Rahban, et al.
Published: (2019-08-01) -
Prognostic Significance of BIRC5/Survivin in Breast Cancer: Results from Three Independent Cohorts
by: Nina Oparina, et al.
Published: (2021-05-01) -
Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?
by: Fengzhi Li, et al.
Published: (2019-08-01)